Logo

Chip Leveille and Mark Solakian

Jun 20, 2007
Chip Leveille has been appointed vice president of sales and marketing and Mark Solakian has been named vice president and general counsel at Helicos Bioscience, the company said this week.
 
Leveille previously served for six years at Affymetrix where he served as vice president in three separate capacities – pharmaceutical business, core technologies group, and corporate marketing.
 

Solakian is also an Affy alumn. He most recently served as vice president and chief corporate counsel for Affymetrix. Prior to joining Affy, Solakian was an attorney at Goodwin Procter in Boston. He holds an AB from Harvard College and a JD from Boston College Law School.

Breaking News
The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.